Folate, also known as vitamin B9 and folacin, is one of the B vitamins.Manufactured folic acid, which is converted into folate by the body, is used as a dietary supplement and in food fortification as it is more stable during processing and storage. Folate is required for the body to make DNA and RNA and metabolise amino acids necessary for cell division.As humans cannot make folate, it is required in the diet, making it an essential nutrient.It occurs naturally in many foods. The recommended adult daily intake of folate in the U.S. is 400 micrograms from foods or dietary supplements.

Folate in the form of folic acid is used to treat anemia caused by folate deficiency. Folic acid is also used as a supplement by women during pregnancy to reduce the risk of neural tube defects (NTDs) in the baby. Low levels in early pregnancy are believed to be the cause of more than half of babies born with NTDs. More than 80 countries use either mandatory or voluntary fortification of certain foods with folic acid as a measure to decrease the rate of NTDs. Long-term supplementation with relatively large amounts of folic acid is associated with a small reduction in the risk of stroke and an increased risk of prostate cancer.There are concerns that large amounts of supplemental folic acid can hide vitamin B12 deficiency.
This report contains market size and forecasts of Folic Acid API in global, including the following market information:
Global Folic Acid API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Folic Acid API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Folic Acid API companies in 2021 (%)
The global Folic Acid API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Folic Acid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Folic Acid API include Shengda Biology, XinHeCheng, Zhejiang Medicine, Hebei Jiheng, Manus Aktteva Biopharma LLP, Gnosis SPA, DSM, Jiangxi Tianxin and Changzhou pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Folic Acid API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Folic Acid API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Folic Acid API Market Segment Percentages, by Type, 2021 (%)
Folic Acid
Compound Folic Acid
Global Folic Acid API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Folic Acid API Market Segment Percentages, by Application, 2021 (%)
Biochemical Research
Clinical Drugs
Nutritious Food
Global Folic Acid API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Folic Acid API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Folic Acid API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Folic Acid API revenues share in global market, 2021 (%)
Key companies Folic Acid API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Folic Acid API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shengda Biology
XinHeCheng
Zhejiang Medicine
Hebei Jiheng
Manus Aktteva Biopharma LLP
Gnosis SPA
DSM
Jiangxi Tianxin
Changzhou pharmaceutical